BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35966023)

  • 1. The impact of COVID-19 non-pharmaceutical interventions on HIV care continuum in China: An interrupted time series analysis.
    Wu X; Wu G; Ma Y; Huang X; Yang Y; Cai Y; Luo G; Ma P; Qiao Y; Chen Y; Lin YF; Gao Y; Zhan Y; Song W; Wang Y; Wang R; Yang X; Sun L; Wei H; Li Q; Xin X; Wang L; Wang X; Xie R; Yang L; Meng X; Zhao J; Li L; Zhang T; Xu J; Fu G; Zou H
    Lancet Reg Health West Pac; 2022 Dec; 29():100569. PubMed ID: 35966023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis.
    Dorward J; Khubone T; Gate K; Ngobese H; Sookrajh Y; Mkhize S; Jeewa A; Bottomley C; Lewis L; Baisley K; Butler CC; Gxagxisa N; Garrett N
    Lancet HIV; 2021 Mar; 8(3):e158-e165. PubMed ID: 33549166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate and long-term outcomes after treat-all among people living with HIV in China: an interrupted time series analysis.
    Wu X; Wu G; Ma P; Wang R; Li L; Sun Y; Xu J; Li Y; Zhang T; Li Q; Yang Y; Wang L; Xin X; Qiao Y; Fang B; Lu Z; Zhou X; Chen Y; Liu Q; Fu G; Wei H; Huang X; Su B; Wang H; Zou H
    Infect Dis Poverty; 2023 Aug; 12(1):73. PubMed ID: 37580822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of COVID-19 on the HIV Cascade of Care in Botswana - An Interrupted Time Series.
    Sehurutshi A; Farooqui H; Chivese T
    AIDS Behav; 2024 Jun; ():. PubMed ID: 38856847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the impact of the COVID-19 restrictions on HIV testing services in Malawi: an interrupted time series analysis.
    Afirima B; Iyamu IO; Yesufu ZA; Iwara E; Chilongozi D; Banda L; Zenengeya E; Mablekisi C; Matatiyo B; Kuye J; Michael O; Gonani A; Ruberintwari M; Madidi N; Oladele E; Akolo C
    Afr J AIDS Res; 2023 Jul; 22(2):92-101. PubMed ID: 37395508
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of the COVID-19 lockdown on the HIV care continuum in Southwestern Uganda: A time series analysis.
    Kabami J; Owaraganise A; Beesiga B; Okiring J; Kakande E; Chen YH; Mwangwa F; Akatukwasa C; Nangendo J; Muyindike W; Semitala FC; Roh ME; Kamya MR
    PLoS One; 2023; 18(8):e0289000. PubMed ID: 37561727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate and long-term changes in infectious diseases in China at the "First-level-response", "Normalized-control" and "Dynamic-COVID-zero" stages from 2020 to 2022: a multistage interrupted-time-series-analysis.
    Shi T; Zhang X; Meng L; Li D; Jin N; Zhao X; Zheng H; Wang T; Li R; Ren X
    BMC Public Health; 2023 Jul; 23(1):1381. PubMed ID: 37464368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of COVID-19 pandemic on Tuberculosis and HIV services in Ghana: An interrupted time series analysis.
    Osei E; Amu H; Kye-Duodu G; Kwabla MP; Danso E; Binka FN; Kim SY
    PLoS One; 2023; 18(9):e0291808. PubMed ID: 37729176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in initiations of HIV treatment in South Africa during the COVID pandemic.
    Benade M; Long L; Rosen S; Meyer-Rath G; Tucker JM; Miot J
    BMC Health Serv Res; 2022 Mar; 22(1):428. PubMed ID: 35361209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-pharmaceutical interventions for COVID-19 reduced the incidence of infectious diseases: a controlled interrupted time-series study.
    Zhang W; Wu Y; Wen B; Zhang Y; Wang Y; Yin W; Sun S; Wei X; Sun H; Zhang Z; Li S; Guo Y
    Infect Dis Poverty; 2023 Mar; 12(1):15. PubMed ID: 36895021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial.
    Molina JM; Grund B; Gordin F; Williams I; Schechter M; Losso M; Law M; Ekong E; Mwelase N; Skoutelis A; Wiselka MJ; Vandekerckhove L; Benfield T; Munroe D; Lundgren JD; Neaton JD;
    Lancet HIV; 2018 Apr; 5(4):e172-e180. PubMed ID: 29352723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antiretroviral therapy initiation time and baseline CD4
    Yang Y; Li Y; Zhang X; Zhang W; Ma Y; Jia X; Gondwe T; Wang Y; Shi X
    Glob Health Action; 2021 Jan; 14(1):1963527. PubMed ID: 34592916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in baseline CD4 cell counts and risk factors for late antiretroviral therapy initiation among HIV-positive patients in Shanghai, a retrospective cross-sectional study.
    Sun J; Liu L; Shen J; Chen P; Lu H
    BMC Infect Dis; 2017 Apr; 17(1):285. PubMed ID: 28420350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of non-pharmaceutical interventions for containing the COVID-19 outbreak in China.
    Lai S; Ruktanonchai NW; Zhou L; Prosper O; Luo W; Floyd JR; Wesolowski A; Santillana M; Zhang C; Du X; Yu H; Tatem AJ
    medRxiv; 2020 Mar; ():. PubMed ID: 32511601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of strategic use of antiretroviral therapy intervention to the HIV continuum of care in 13 cities in Indonesia: an interrupted time series analysis.
    Tarigan YN; Woodman RJ; Miller ER; Wisaksana R; Ward PR
    AIDS Res Ther; 2021 Apr; 18(1):22. PubMed ID: 33902631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the coronavirus disease 2019 interventions on the incidence of hand, foot, and mouth disease in mainland China.
    Zhao Z; Zheng C; Qi H; Chen Y; Ward MP; Liu F; Hong J; Su Q; Huang J; Chen X; Le J; Liu X; Ren M; Ba J; Zhang Z; Chang Z; Li Z
    Lancet Reg Health West Pac; 2022 Mar; 20():100362. PubMed ID: 35005671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seasonal variations in tuberculosis diagnosis among HIV-positive individuals in Southern Africa: analysis of cohort studies at antiretroviral treatment programmes.
    Ballif M; Zürcher K; Reid SE; Boulle A; Fox MP; Prozesky HW; Chimbetete C; Zwahlen M; Egger M; Fenner L;
    BMJ Open; 2018 Jan; 8(1):e017405. PubMed ID: 29330173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological trend in scarlet fever incidence in China during the COVID-19 pandemic: A time series analysis.
    Ma Y; Gao S; Kang Z; Shan L; Jiao M; Li Y; Liang L; Hao Y; Zhao B; Ning N; Gao L; Cui Y; Sun H; Wu Q; Liu H
    Front Public Health; 2022; 10():923318. PubMed ID: 36589977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial.
    Kunisaki KM; Niewoehner DE; Collins G; Aagaard B; Atako NB; Bakowska E; Clarke A; Corbelli GM; Ekong E; Emery S; Finley EB; Florence E; Infante RM; Kityo CM; Madero JS; Nixon DE; Tedaldi E; Vestbo J; Wood R; Connett JE;
    Lancet Respir Med; 2016 Dec; 4(12):980-989. PubMed ID: 27773665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of COVID-19 pandemic on HIV care continuum in Jiangsu, China.
    Shi L; Tang W; Hu H; Qiu T; Marley G; Liu X; Chen Y; Chen Y; Fu G
    BMC Infect Dis; 2021 Aug; 21(1):768. PubMed ID: 34364383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.